Centrica PLC has announced that two of its executive directors, Christopher O'Shea and Russell O'Brien, have acquired ordinary shares through the company's Share Incentive Plan. The shares were acquired through reinvestment of the company's 2023 final dividend of 2.67 pence per share. Christopher O'Shea acquired 376 shares at a price of £1.4074 per share, totaling £529.18, while Russell O'Brien acquired 75 shares at the same price, totaling £105.56. The transactions were conducted on the London Stock Exchange on 11 July 2024.

The notifications were made pursuant to Article 19 of the Market Abuse Regulation. Equiniti Share Plan Trustees Limited facilitated the acquisitions on behalf of the directors. Centrica PLC is listed on the London Stock Exchange and has its registered office in Windsor, Berkshire. The company's Legal Entity Identifier number is E26EDV109X6EEPBKVH76.